PHARMACEUTICAL EXECUTIVE NEWSLETTER

In this ISSUE

Pharm Exec's 2018 Industry Forecast

Building on Brand Awarness to Improve Brand Adoption and Conversion Rates

New Horizons for Investors in the Ukranian Pharma Market

Top Story

Insights from J.P. Morgan 2018

Mark O'Connor looks at what we learned from this year's J.P. Morgan Healthcare Conference
… /Read more/

A Molecule’s Journey - Breaking Down Roadblocks to Commercial Success
In this guidebook, our experts share some key considerations to help biopharmaceutical companies successfully advance a molecule from the laboratory to the clinic as quickly as possible without sacrificing product quality, process efficiency, or patient safety.

Download the White Paper »

Europe

European HTA is on Its Way — At Last

It's taken a long time, but the European Union is at last trying to corral its numerous health technology assessment bodies into some form of standardization. Reflector reports.
… /Read more/

New Video Series! COMMERCIAL INSIGHTS into DIGITAL TRENDS – In this video series, produced in partnership with Veeva Systems, Pharmaceutical Executive speaks with biopharma and industry experts about the future of life sciences commercial capabilities and the hottest trends affecting this important market segment. Filmed live at the 9^th Annual Veeva Systems' Global Commercial and Medical Summit.

Learn more

New Feature

The Pharm Exec Podcast:
Episode 1

In the first episode of Pharm Exec's new podcast series, the editors talk about the expected pharma trends for 2018 and reflect on key takeaways from recent high-profile conferences
… /Read more/

Regulatory Information Management Best Practices
Read this Executive Summary to learn how to reduce regulatory complexity, ensure data quality and improve the user experience while ensuring compliance.

Download Now

Calendar

/ February 7–8: Speaker Programs 2018 /

Philadelphia, PA

/ March 19–22: DCAT Week '18 /

New York, NY

/ March 25–28: 14^th Annual Pharma Forum /

Philadelphia, PA

/ March 28–29: Expanded Access Programs /

Washington, DC

/ April 10–12: LogiPharma 2018 /

Montreux, Switzerland

/ April 11–12: 8^th Annual Global Transparency Reporting Congress /

London, UK

/ May 10–11: Pharma Marketing Summit /

Palm Beach, FL

/ October 15–17: 28^th Annual Sharing Conference: Compliance /

National Harbor, MD

Maximizing Medical Affairs Impact through Strategic Alignment and Collaboration: Best Practice and Live Benchmarking
On Demand

Learn more

Marketing

Listening Is the Key to Becoming More Than Just Better Marketers

How much better would our creative be if we took the time to really listen to what our clients are saying – and what they are not saying? Nancy Beesley reports
… /Read more/

CRO Consolidation: A Sinister Threat or Windfall for Pharma?
Live Webcast: Tuesday, March 27 at 1:00pm EDT

Global

Compliance in China: Key Considerations

Outlining the procedures to manage anti-corruption risk that life sciences companies should consider before doing business in China
… /Read more/

The Rare Disease Revolution
On Demand

Learn more

Industry update

// CURE Pharmaceutical (Los Angeles, CA) named Dr. Vered Gigi asVice President of Strategy and Business Development. // Akari Therapeutics (New York, NY, and London, UK) announced the appointment of Michael Grissinger and Dr. Peter Feldschreiber to the company's Board of Directors. // Dr. Scott Lyon joined the North America office of Optibrium (Cambridge, UK) as Director of Business Development. // Linda Law, M.D., was appointed US Vice President, Clinical Development and Medical Affairs of Advicenne (Nîmes, France) to oversee the company's clinical development and medical affairs efforts in North America. //

advertise with us / print subscribe / digital subscribe / visit pharmexec.com